Cerebral protection combines techniques aimed 1) to avoid death of neu
rones which sustained primary ischemic of traumatic insults and 2) to
prevent secondary insults to the brain. The chemical brain retractor c
oncept includes the use of a total intravenous anesthesia technique, m
ild hypocapnia and mannitol with strict monitoring and maintenance of
the global cerebral homeostasis. This contributes to decrease brain vo
lume and intracranial pressure and allows the best possible access to
the operating site, while avoiding excessive pressure under the surgic
al brain retractors. Neuronal protection is based on a better understa
nding of the biological basis of secondary brain damage; therapeutic o
r prophylactic techniques include the use of specific pharmacological
agents, hypothernia, hemodilution and maintenance of an elevated cereb
ral perfusion pressure. In short, although the fav ourable effects of
such techniques are nor easy to demonstrate in man, their use in today
's clinical practice, in association with the concept of the chemical
brain retractor, is an effective way to prevent ischemic cerebral insu
lts during neurosurgical procedures.